OBJECTIVE: To discuss the expression features of serum cystatin C, and homocysteine in patients of Parkinson's disease (PD) with mild cognitive impairment. PATIENTS AND METHODS: Patients with PD from the neurology department of the Central Hospital of Xuzhou from august 2012 to august 2014 were enrolled in this study. The Hoehn-Yahr (H&Y) grading rating scale was used to rate the degree of severity of PD, and the Mini-Mental State Examination (MMSE) and Montreal Cognitive Assessment (MoCA) rating scale was used to rate and group their cognitive impairment, test the level of the serum cystatin C (CysC) and homocysteine (HCY) and their variations after treatment with vitamin B and folic acid. RESULTS: (1) The CysC and HCY in the PD group was higher than that in the normal control (p<0.05); (2) As the H&Y rating upgraded, the CysC and HCY in the PD group gradually increased with the progression of the disease (p<0.05); (3) The level of CysC and HCY in the PD-mild cognitive impairment (MCI) group increased significantly compared with those in the PD group (p<0.05) The correlation analysis showed that there was significant positive correlation between CysC and HCY. (4) After treatment with vitamin B and folic acid, the CysC, and HCY levels were lower than before, but the grades of the repetition measurement scale, MMSE and MoCA had no significant improvement (p>0.05). CONCLUSIONS: A high level of CysC and HCY might be involved in the development of Parkinson disease. Their expression levels were higher in the PD patients with mild cognitive dysfunction and both showed a remarkably positive correlation.
OBJECTIVE: To discuss the expression features of serum cystatin C, and homocysteine in patients of Parkinson's disease (PD) with mild cognitive impairment. PATIENTS AND METHODS: Patients with PD from the neurology department of the Central Hospital of Xuzhou from august 2012 to august 2014 were enrolled in this study. The Hoehn-Yahr (H&Y) grading rating scale was used to rate the degree of severity of PD, and the Mini-Mental State Examination (MMSE) and Montreal Cognitive Assessment (MoCA) rating scale was used to rate and group their cognitive impairment, test the level of the serum cystatin C (CysC) and homocysteine (HCY) and their variations after treatment with vitamin B and folic acid. RESULTS: (1) The CysC and HCY in the PD group was higher than that in the normal control (p<0.05); (2) As the H&Y rating upgraded, the CysC and HCY in the PD group gradually increased with the progression of the disease (p<0.05); (3) The level of CysC and HCY in the PD-mild cognitive impairment (MCI) group increased significantly compared with those in the PD group (p<0.05) The correlation analysis showed that there was significant positive correlation between CysC and HCY. (4) After treatment with vitamin B and folic acid, the CysC, and HCY levels were lower than before, but the grades of the repetition measurement scale, MMSE and MoCA had no significant improvement (p>0.05). CONCLUSIONS: A high level of CysC and HCY might be involved in the development of Parkinson disease. Their expression levels were higher in the PDpatients with mild cognitive dysfunction and both showed a remarkably positive correlation.
Authors: Robert C Kalayjian; Kevin R Robertson; Jeffrey M Albert; Carl J Fichtenbaum; Todd T Brown; Babafemi O Taiwo Journal: J Acquir Immune Defic Syndr Date: 2019-06-01 Impact factor: 3.731
Authors: María Teresa Periñán; Daniel Macías-García; Silvia Jesús; Juan Francisco Martín-Rodríguez; Laura Muñoz-Delgado; Maria Valle Jimenez-Jaraba; Dolores Buiza-Rueda; Marta Bonilla-Toribio; Astrid Daniela Adarmes-Gómez; Pilar Gómez-Garre; Pablo Mir Journal: J Neurol Date: 2022-09-28 Impact factor: 6.682